Oregonians in 57 cities and 26 of the state’s 36 counties will vote in November on banning or postponing psilocybin treatment centers and the production of psilocybin products in their areas.
Psilocybin was first approved by state voters in 2020 with almost 56% of the vote supporting Measure 109. The vote made Oregon the first state in the nation to legalize such treatment. The program will be launched by the Oregon Health Authority in January.
But the measure included a process for cities and counties to back out of legalization, allowing a vote on local bans or a two-year moratorium before joining the rest of the state. They had until Aug. 19 to file paperwork with the Secretary of State’s office to put it on the November ballot.
At least 27 cities have ensured access to psilocybin treatment, including 17 of the state’s most populous cities.
Psilocybin is a hallucinogenic substance found in some mushrooms that has been shown to effectively treat anxiety, depression and post traumatic stress disorder.
A slight majority of residents in Deschutes County, about 53%, voted to approve Measure 109 in 2020, helping to get it passed statewide. But the county’s commissioners recently opted to put the question on the November ballot by a 2-to-1 vote.
Commissioner Phil Chang was the lone dissenter.
At a press conference Tuesday, Chang said he did so because counties have a responsibility to make sure residents can get needed medical care. Counties “are the local public health authorities for their communities,” he said. “I want people in my community to have access to effective treatments.”
Sam Chapman, executive director of the nonprofit Healing Advocacy Fund, which is supporting the rollout of Measure 109, also said at the news conference medical centers offering psilocybin treatments and psilocybin manufacturers will be regulated by the Oregon Health Authority. A draft of the final rules will be ready in September, and will be finalized and adopted by the agency by Dec. 31. The health authority will begin taking applications for treatment centers and providers on Jan. 2.
Chapman said the 27 cities committed to adopting psilocybin therapy represent about 2 million people, so nearly half of Oregon’s population will have access to the treatment in their community. Others, he said, will come for psilocybin therapy from outside the state.
“Oregon will become a destination of sorts for people who don’t want to leave the country for this treatment, which is currently the only option,” he said.
Counties that will vote on banning or postponing psilocybin treatment and production:
Clackamas, Deschutes, Jackson, Marion, Linn, Coos, Malheur, Morrow, Baker, Douglas, Grant, Clatsop, Crook, Gilliam, Harney, Jefferson, Josephine, Klamath, Lake, Polk, Sherman, Tillamook, Umatilla, Union, Wallowa, Wheeler
Cities that will vote on banning or postponing psilocybin treatment and production:
Coos Bay, Pendleton, Roseburg, Winston, Seaside, Prineville, Newberg, Sandy, Nyssa, Vale, Jordan Valley, Philomath, Toledo, St. Helens, Lebanon, La Grande, Cove City, Keizer, McMinnville, Redmond, Newberg, Prineville, Pendleton, Roseburg, Sheridan, Stayton, Silverton, Scotts Mills, Falls City, Cornelius, Metolius, Madras, Culver, Coquille, North Bend, Lakeside, La Pine, Canyonville, Oakland, Glendale, Eagle Point, Dunes City, Junction City, Harrisburg, Millersburg, Tangent, City of Umatilla, Myrtle Creek, Drain, Reedsport, Cascade Locks, Cottage Grove, Brownsville, Lyons, Irrigon, Boardman
Oregon Capital Chronicle is part of States Newsroom, a network of news bureaus supported by grants and a coalition of donors as a 501c(3) public charity. Oregon Capital Chronicle maintains editorial independence. Contact Editor Lynne Terry for questions: firstname.lastname@example.org. Follow Oregon Capital Chronicle on Facebook and Twitter.